Business
CSL (ASX:CSL) share price lower amid reported mRNA vaccine delays
Image source: Getty Images
The CSL Limited (ASX: CSL) share price is falling amid reports Australia might not be capable of producing mRNA vaccines until 2023.
Right now, shares in CSL are swapping hands for $276.09 – 1.33% less than yesterday’s closing price.
The fall…
Continue Reading
-
Noosa News14 hours agoAustralian chocolate gains a competitive edge in global cocoa shortage
-
General24 hours agoFormer Victorian Liberal leader John Pesutto to avoid bankruptcy after party agrees to loan him $1.55m
-
General23 hours agoUK rates on hold due to ‘highly unpredictable’ world
-
General13 hours agoAustralia’s Iran embassy staff leave after US warning